Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients

PURPOSE: To investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients. METHODS: We retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eye (Lond)
Asıl Yazarlar: Kim, G A, Rim, T H, Lee, S C, Byeon, S H, Koh, H J, Kim, S S, Lee, C S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2015
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4469674/
https://ncbi.nlm.nih.gov/pubmed/25952951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.58
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller